- Home
- MERC vs HYFT Comparison
MERC vs HYFT Comparison
Compare MERC & HYFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MERC | HYFT |
|---|---|---|
| Founded | 1968 | 1983 |
| Country | Canada | United States |
| Employees | N/A | 102 |
| Industry | Paper | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.2M | 66.8M |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | MERC | HYFT |
|---|---|---|
| Price | $0.59 | $1.31 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $2.25 | ★ $5.00 |
| AVG Volume (30 Days) | ★ 492.3K | 221.9K |
| Earning Date | 05-07-2026 | 03-12-2026 |
| Dividend Yield | ★ 7.01% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,169,145,000.00 | N/A |
| Revenue This Year | $13.75 | N/A |
| Revenue Next Year | $10.12 | $29.18 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 25.50 | N/A |
| 52 Week Low | $0.53 | $0.99 |
| 52 Week High | $3.38 | $3.00 |
Technical Indicators
Market Signals| Indicator | MERC | HYFT |
|---|---|---|
| Relative Strength Index (RSI) | 48.62 | 42.26 |
| Support Level | $0.54 | $1.17 |
| Resistance Level | $0.72 | $1.44 |
| Average True Range (ATR) | 0.06 | 0.13 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 60.48 | 41.03 |
Price Performance
Historical ComparisonAbout MERC Mercer International Inc.
Mercer International Inc is a forest products company with two reportable operating segments in pulp and solid wood. The pulp segment consists of the manufacture, sale, and distribution of pulp, electricity, and chemicals. The company has a geographical presence in the USA, Germany, China, and Other countries, where the maximum of revenue is generated from the China. The majority of the revenue is generated from the Pulp segment.
About HYFT MindWalk Holdings Corp.
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.